伏立康唑-voriconazole
注释ID
1450664415
变量_单倍型
rs763625282
基因
CYP2C19
药物名称(英)
voriconazole
药物名称(中)
伏立康唑
PMID
30464555
类型
Metabolism/PK
含义
yes
记事
Caution: M136K amino acid change might or not be together with W212X. No information about the gene construct generation used for the assay, the article names the variant *3C (M136K). In table 1 it lists W212X as effect for *3C. However it is not clear if the *3 signature SNP (W212X) is included in the *3C M136K construct since the *3 signature SNP construct by itself results in not detectable enzyme activity. Intrinsic clearance is Vmax/Km. Relative clearance for M136K is 24.63% compared to *1 (no variants).
专家论述
Allele A is associated with decreased clearance of voriconazole in insect microsomes as compared to allele T.
等位基因
A
专家评论
变体注释摘要
id研究类型特征类型
26809 Unknown
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3